Substrate AIa Valencian artificial intelligence company listed on BME Growth, has hired the consulting firm LKS Next to prepare the IPO of its subsidiary 4D Médica.
LKS Next is part of the Mondragon Corporation and has a total of 800 professionals specialized in the industrial, technological and health sectors. Its experience includes mergers, acquisitions and capital markets advisory servicesand, therefore will assist Substrate AI in preparing for the IPO.. From the preparation of the necessary documentation, the choice of the most suitable market for the initial public offering (IPO) and the search for investors, considering the particularities of 4D Médica's business.
Acquisition of 4D Medical by Substrate AI
Substrate AI acquired the 70% from 4D Medical in 2022 for 1.4 million euros. 4D Médica was originally dedicated to the sale of diagnostic imaging hardware for the veterinary sector.under the direction of its founder and CEO, Francesc Ramos, with more than 20 years of experience in the sector.
After the acquisition, the company was transformed into a AI applied to diagnostic imagingwith hardware and software divisions, operating in both veterinary and human medicine.
The purchase of Diagximag is integrated into the subsidiary 4D Médica
In 2023, Substrate AI purchased Diagximaga company focused on hardware for human medicine and main distributor of Samsung in Spain.integrating it with 4D Medical. In addition, we developed a AI-based imaging software to help doctors and veterinarians obtain more accurate diagnoses, which will soon also be available for human medicine.
This software seeks to Improve disease diagnosis and reduce radiation exposure to patients and physicians. by means of collimator self-regulation in ionizing radiation equipment.
4D Médica's sales growth since 2021
Thanks to these initiatives, 4D Médica has tripled its sales in three years1.8 million in 2021 to a figure three times higher in 2024, while maintaining an EBITDA margin of more than 25%.
"We are very satisfied with the road we have traveled in just two years. Together with Substrate AI, and thanks to their technology and support, we have transformed the company and prepared ourselves to become one of the key players in the application of AI to diagnostic imaging, an essential part of current and future medicine," says Francesc Javier Ramos, CEO of 4D Médica.
Therefore, the next step is the joint work of LKS Next, Substrate AI and 4D Médica to ensure that the IPO fits the needs of the company's growth plan.
CEO of 4D Médica. Expert in marketing and distribution of medical equipment.
EN 
ES 
FR 